Those with BMI of 35 and a comorbidity could be prescribed tirzepatide and Nice says it is more effective than Wegovy
The medical treatment regulator for England has approved a second drug to combat obesity, giving patients and doctors what it says is a more effective alternative to semaglutide.
The National Institute for Health and Care Excellence (Nice) issued draft guidance on Tuesday recommending that very obese people should be prescribed tirzepatide, which is marketed in the UK as Mounjaro.
About Author
More Stories
Memo to Trump: US telecoms is vulnerable to hackers. Please hang up and try again | John Naughton
Bizarre Australian mole even more unusual than first thought, new research reveals
Male mosquitoes to be genetically engineered to poison females with semen in Australian research